Gilead Sciences, Foster City, California, USA

International Antiviral News

Volumn 4, Issue 9, 1996, Pages 171-174

  Goldthorpe Stein, S E ^a   Hitchcock, M J M ^a   Milligan, J F ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADEFOVIR DIPIVOXIL; ANTIVIRUS AGENT; CIDOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DOUBLE BLIND PROCEDURE; DRUG DESIGN; DRUG STRUCTURE; HEPATITIS B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RETINITIS; SHORT SURVEY;

EID: 0030480125     PISSN: 09652310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)